Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Mathematical model helps predict the risk of COVID-19 transmission in a train carriage

Researchers have demonstrated how airborne diseases such as COVID-19 spread along the length of a train carriage and found that there is no 'safest spot' for passengers to minimise the risk of transmission.

22 Jun 2022

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

Scientists have described the clinical outcomes in hospitalized COVID-19 patients who have been treated with JNK inhibitors together with standard of care.

22 Jun 2022

The role of smartphone apps during the COVID-19 pandemic

In a recent study published in Nature Biotechnology, researchers assessed the role of smartphone apps during the coronavirus disease 2019 (COVID-19) pandemic.

22 Jun 2022

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

In a recent review published in Immunity, researchers explored potential mechanisms of neuro-immune pathophysiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections.

22 Jun 2022

Research details patterns of COVID and long COVID symptoms across 42,000 individuals

In a recent study posted to the medRxiv* pre-print server, researchers examined 42,000 participants from nine longitudinal studies conducted in the United Kingdom (UK) to analyze the prevalence of coronavirus disease 2019 (COVID-19) symptoms and characterize long COVID symptom patterns.

21 Jun 2022

Moderna to build large-scale mRNA manufacturing center in the UK

NHS patients will have access to the next generation of vaccines and treatments following an agreement between the government and Moderna to build a state-of-the-art manufacturing and research and development centre in the UK.

21 Jun 2022

Simplicity is key when it comes to ablation, global AFib study finds

Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the simple approach is usually best when it comes to ablation, a procedure where physicians destroy or ablate cardiac tissue to correct irregular heart rhythms.

21 Jun 2022

Childhood bronchitis increases the risk of lung diseases in adult life

Bronchitis in early childhood has been found to increase the risk of lung diseases in middle age according to research from the Allergy and Lung Health Unit at the University of Melbourne.

21 Jun 2022

INTEGRA pipettes simplify PCR testing for COVID-19

Matrix Diagnostics – a dedicated COVID-19 testing lab in California – is relying on INTEGRA Biosciences’ EVOLVE and MINI 96 pipettes to streamline and accelerate its PCR workflows

From INTEGRA Biosciences 21 Jun 2022

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers comparatively assessed the generation of B lymphocyte-mediated antibody responses and T lymphocyte-mediated cellular responses between mRNA BNT162b vaccinees and mild COVID-19 patients.

21 Jun 2022

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

A new study reported four cases of Myelin Oligodendrocyte Glycoprotein-Associated Disorder that commenced after SARS-CoV-2 infection.

21 Jun 2022

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

E-cigarettes have become increasingly popular among adolescents, and the latest available scientific evidence suggests the use of these products has adverse health effects that may accrue over time, leading to an increased risk of cardiovascular and pulmonary disease over the course of the life of people who use e-cigarettes, according to a new scientific statement from the American Heart Association published today in the Association's peer-reviewed journal, Circulation: Research.

21 Jun 2022

How specific comorbidities impact severity of COVID-19

Researchers identify the association between severe COVID-19 and specific comorbidities.

20 Jun 2022

Is SARS-CoV-2 a seasonal virus?

In a recent study posted to the medRxiv* pre-print server, scientists at Pfizer Inc determined whether coronavirus disease 2019 (COVID-19) case rates in the United States (US) and European (EU) nations followed a seasonal pattern using a time series model.

20 Jun 2022

UTSW study provides a potential avenue for the development of new antivirals against influenza

A collaborative study from UT Southwestern scientists has identified a new function for a protein called TAO2 that appears to be key to inhibiting replication of the influenza virus, which sickens millions of individuals worldwide each year and kills hundreds of thousands.

20 Jun 2022

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

In a recent study posted to the bioRxiv* preprint server, researchers at Weill Cornell Medical College assessed the cleavability of the spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) and related coronaviruses by several proteases of the host.

19 Jun 2022

CDC posts notice regarding multistate Salmonella outbreaks linked to contact with backyard poultry

A CDC investigation notice regarding multistate outbreaks of Salmonella infections has been posted: https://www.cdc.gov/salmonella/backyardpoultry-06-22/index.html

19 Jun 2022

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

When a person sneezes or coughs, they can potentially transmit droplets carrying viruses like SARS-CoV-2 to others in their vicinity.

17 Jun 2022

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

Researchers reported on the misclassification of the SARS-CoV-2 Omicron BA.1 subvariant as Omicron BA.2 subvariant in an automated variant-specific polymerase chain reaction analysis.

17 Jun 2022

GPR183 gene a novel drug target for severe COVID-19

In a recent study posted to the bioRxiv* pre-print server, researchers provide the first preclinical evidence of the usefulness of antagonists of G-protein coupled receptor 183 (GPR183), also known as Epstein-Barr virus-induced gene 2 (EBI2), in reducing coronavirus disease 2019 (COVID-19) severity.

17 Jun 2022

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Mathematical model helps predict the risk of COVID-19 transmission in a train carriage

Scientists evaluate JNK inhibitors in treating moderate to severe COVID-19 patients

The role of smartphone apps during the COVID-19 pandemic

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

Research details patterns of COVID and long COVID symptoms across 42,000 individuals

Moderna to build large-scale mRNA manufacturing center in the UK

Simplicity is key when it comes to ablation, global AFib study finds

Childhood bronchitis increases the risk of lung diseases in adult life

INTEGRA pipettes simplify PCR testing for COVID-19

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

New scientific statement highlights the cardiopulmonary effects of e-cigarette use among adolescents

How specific comorbidities impact severity of COVID-19

Is SARS-CoV-2 a seasonal virus?

UTSW study provides a potential avenue for the development of new antivirals against influenza

SARS-CoV-2 variants of concern exhibit divergent interactions with host proteases

CDC posts notice regarding multistate Salmonella outbreaks linked to contact with backyard poultry

Researchers analyze SARS-CoV-2 virus transmission by speech aerosols during short conversations

SARS-CoV-2 variant-specific polymerase chain reaction assay for SARS-CoV-2 genomic surveillance

GPR183 gene a novel drug target for severe COVID-19

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in